Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Roger Herr, PT, MPA

Mar 3, 2022/Author

Roger Herr, PT, MPA, is APTA President for a three-year term of 2021 through 2023.

Confirming and Reaffirming

Oct 1, 2021/Column

Defining moments can come more than once in life, as with a move to America, the birth of a baby, starting a practice, and a being thrown a curveball.

Patient-Reported Outcomes Measurement Information System Global-10, PROMIS Global-10

May 16, 2019/Test & Measure

Assesses health care-related quality of life measures for the general population.

White Paper: Beyond Opioids: How Physical Therapy Can Transform Pain Management to Improve Health

Jan 1, 2021/White Paper

No lasting gains can be made in the opioid fight until the value of nonpharmacological approaches to chronic pain are recognized.

Outstanding PT Student and PTA Student Awards

This award identifies a student member with exceptional overall accomplishments and contributions to APTA and the physical therapy profession.

Coronavirus Update: August 24

Aug 24, 2022/Roundup

Physical activity's role in reducing COVID-19 risk, prone positioning, new CDC recommendations, home testing, and more.

Viewpoints

Nov 1, 2017/Magazine

Ask Questions. Remember Wellness.

Medicare Payment Changes: 2022

Jan 7, 2022/Resource

We've compiled a summary on the numerous changes to 2022 Medicare regulations related to payment under the Physician Fee Schedule, the PTA differential, remote therapeutic monitoring codes, and more.

July Advocacy Roundup: How Nearly a Decade of Advocacy Helped APTA Lead the Way on Aetna’s Direct Access Policy Change

Jul 22, 2025/Podcast

In this episode, Alice Bell, PT, DPT, senior specialist, health policy and payment, is joined by Wanda Evans, PT, DPT, MHS, senior specialist, health policy and payment, to discuss how APTA advocacy led to Aetna’s decision to provide unrestricted direct access to physical therapist services.

IMPROVE VTE Risk Model

Oct 31, 2021/Test & Measure

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1